Broad syntheses related to this topic

loading
8 References (8 articles) loading Revert Studify

Broad synthesis / Overview of systematic reviews

Unclassified

期刊 Pediatrics
Year 2023
Loading references information
BACKGROUND: Multiple systematic reviews examine the introduction of foods in relation to individual health outcomes, but the balance of harms and benefits has not been overviewed systematically. OBJECTIVES: We aimed to perform an overview of systematic reviews on age of introduction of complementary and allergenic foods to the infant diet and long and short-term health outcomes. DATA SOURCES: We searched Medline, Embase, Cochrane, and PubMed (July 25, 2022). STUDY SELECTION: Included systematic reviews examining the introduction of complementary or allergenic foods before age 1. Outcomes included allergic, autoimmune, and inflammatory diseases, neurodevelopment, nutrition, and weight. DATA EXTRACTION: Extraction and quality assessment were performed in duplicate (A Measurement Tool to Assess Systematic Reviews) and strength of evidence was assessed. RESULTS: We screened 4015 articles and included 32 systematic reviews. There was moderate evidence that peanut and egg should be introduced from 4 to 11 months to prevent food allergy (6 of 10 reviews). Complementary food introduction was not associated with food allergy. Moderate certainty evidence suggested age of complementary food introduction was not associated with eczema. Age at introduction of gluten was not associated with celiac disease (high certainty evidence; 3 of 4 reviews). Low certainty evidence indicated that introducing solids before 4 months may increase the risk of childhood obesity, but not growth. There was insufficient evidence regarding an association between any food introduction and bone health, gastrointestinal diseases, autoimmune disorders, asthma, or allergic rhinitis. LIMITATIONS: Gray literature was not included. CONCLUSIONS: Current evidence supports introducing complementary foods around 6 months and allergenic foods before 11 months.

Broad synthesis / Overview of systematic reviews

Unclassified

期刊 Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Year 2023
Loading references information
Objective: To summarise and critically appraise systematic review (SR) evidence on the effects of timing of complementary feeding (CF) on the occurrence of allergic sensitisation and disease. Design: Overview of SRs. AMSTAR-2 and ROBIS were used to assess methodological quality and risk of bias (RoB) of SRs. RoB 2 Tool was used to assess RoB of primary randomised controlled trials (RCTs) (or extracted). The certainty of evidence (CoE) was assessed using GRADE. Findings were synthesised narratively. Data Sources: MEDLINE (via PubMed and Ovid), the Cochrane Library and Web of Science Core Collection (2010 to 27 February 2023). Eligibility Criteria: SRs investigating the effects of timing of CF in infants or young children (0–3 years) on risk of developing food allergy (FA), allergic sensitisation, asthma, allergic rhinitis, atopic eczema and adverse events based on RCT evidence. Results: Eleven SRs were included. Only two SRs had low RoB; common issues were failure to report on funding of primary studies and failure to provide a list of excluded trials. Common limitations of included trials were lack of blinding of outcome assessment or detailed trial preregistration, and inadequate handling of high loss to follow up. Primary study overlap was very high for specific FA and slight to moderate for FA in general and other primary outcomes. Introducing specific foods (peanut, cooked egg) early probably reduces the risk of specific FA. Evidence for other allergic outcomes was mostly very uncertain and based on few primary studies. Trials varied regarding timing of CF, nature of complementary foods and population risk, which limited comparability between SRs. Conclusions: For developing guidelines to support decision-making on the timing of CF as a preventive strategy, early introduction of specific foods (i.e. egg and peanut) seems promising and safe, whereas more extensive research is required regarding other allergic outcomes and potential adverse events. © 2023 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd.

Broad synthesis / Overview of systematic reviews

Unclassified

期刊 Clinical nutrition (Edinburgh, Scotland)
Year 2022
Loading references information
BACKGROUND & OBJECTIVE: It has been suggested that prenatal vitamin D plays a role in the development of childhood asthma and wheeze. Several systematic reviews have been conducted, but the results are inconsistent, and the methodological quality has not been studied. Therefore, the objective of this umbrella review was to assess the internal validity of the evidence base and the evidence for an association between prenatal vitamin D and asthma or wheezing in the offspring. METHODS: We searched the electronic databases Embase, PubMed, and Cochrane Library for studies on prenatal vitamin D using search words such as vitamin D, 25-hydroxyvitamin D, calcidiol, fetal, and neonatal. The search was conducted in June 2020, and the databases were searched from their date of establishment. We included systematic reviews and/or meta-analyses of experimental and observational studies assessing the association between prenatal vitamin D or asthma and wheeze. We excluded narrative reviews, commentaries, and other umbrella reviews. The methodological quality of systematic reviews was assessed using AMSTAR 2 tool. PROSPERO reg. no. CRD42020151329. RESULTS: We identified 22 eligible systematic reviews (17 on asthma and 20 on wheeze). Using the AMSTAR 2 quality assessment tool, the methodological quality was rated as critically low in 21 out of 22 systematic reviews, suggesting that previous reviews and meta-analyses did not provide accurate and comprehensive summaries of the included studies and that conclusions reached were potentially flawed. The majority of the included reviews reported that prenatal vitamin D reduces the risk of wheeze in the offspring. CONCLUSION: Prior to informing public guidelines, high-quality systematic reviews of the current evidence are greatly warranted.

Broad synthesis / Guideline

Unclassified

Loading references information
背景:过敏性疾病的婴儿,其父母和兄弟姐妹没有过敏的患病率,为10%左右,并到达在那些与变态反应性相对的第一度20-30%。肠道菌群可调节免疫和炎症的全身反应,因此增感和过敏的影响发展。益生菌已经报道调节免疫应答和其补充已经被提出作为一种预防性干预。 目的:世界变态反应组织(WAO)召开了指导小组,制定有关预防过敏的益生菌证据为基础的建议。 方法:我们确定最相关的临床问题进行,并为益生菌预防过敏的随机对照试验的系统评价。其次,我们的建议评估,开发和评估(级)方法的分级,提出建议。我们搜索了回顾和对健康的影响,患者的价值观和喜好,以及资源利用(最多至2014年11月)的证据。我们遵循的GRADE证据到决策框架,提出建议。 结果:目前现有的证据并不表明益生菌补充剂降低开发过敏患儿的风险。但是,考虑到在这种情况下所有关键的结果,所述的WAO准则面板判断为存在来自使用主要因预防湿疹的益生菌可能净利益。该WAO指南小组建议:1)使用的孕妇在高风险的益生菌对于具有过敏的孩子; b)中谁在开发过敏高危婴儿哺乳的女性益生菌;和c)使用益生菌的婴幼儿在发展过敏的高危人群。所有的建议都是有条件的,并支持低质量的证据。 结论:关于补充益生菌预防过敏WAO建议是为了赡养父母,医生和其他卫生保健专业人士在决定是否使用益生菌在怀孕和哺乳期间,以及是否给他们的婴儿。

Broad synthesis / Overview of systematic reviews

Unclassified

期刊 American journal of preventive medicine
Year 2012
Loading references information
背景:哮喘是一种慢性呼吸系统疾病越来越普遍,在美国,尤其是儿童和某些少数群体。这把伞审查旨在评估和总结现有的系统评价,与哮喘相关的干预措施可能进行或支持由国家或社会的哮喘控制程序,并找出知识上的差距。 证据采集:2010年9月11数据库中搜索,通过使用相关的四个概念:哮喘,审查,干预和不药而愈。评论的有效性的药物,医疗程序,补充和替代医学,心理干预,家庭治疗和营养物质或营养补充品被排除在外。两个编码器筛选每个记录和提取数据所包含的评论。 证据合成:从5月至2010年12月进行数据分析。42个,包括检讨,19的教育和/或自我管理的有效性进行评估,九减少室内触发器,九干预措施以改善所提供的医疗服务,并研究了其他干预措施。一些评论发现一致的证据有效性的自我管理教育,并审查确定,以家庭为基础的综合干预措施,包括减少多个室内的哮喘触发因素是对儿童有效。审查发现证据有限或不足,因为研究的局限性。 结论:国家或社区的哮喘控制计划应优先考虑:(1)实施干预,本审查发现证据的有效性和(2)尚未得到充分评估,评估有希望的干预。

Broad synthesis / Overview of systematic reviews

Unclassified

期刊 Evidence-based child health : a Cochrane review journal
Year 2011
Loading references information
背景:湿疹是最常见的炎症性皮肤疾病的儿童,特点是发痒的红色皮疹,通常涉及面部及皮肤皱褶。目前还没有有效的治疗湿疹,通过疾病预防湿疹的发病率降低是一个理想的目标。可能的干预措施,以防止湿疹时,包括纯母乳喂养,水解蛋白配方和大豆配方奶瓶喂养,避免产妇抗原,欧米茄油的补充,益生元和益生菌。目的:本概述的评论的目的是介绍当前机构的数据从Cochrane系统和非科克伦评论,提供最先进的最新证据的有效性和安全性的干预措施,以防止湿疹的婴儿和儿童在不同的风险水平过敏性疾病的发展。方法:我们的游泳池Cochrane和非科克伦评论来自2010年英国国民健康服务(NHS)的证据皮肤病年度证据更新测绘工作对特应性湿疹。这组用了一个全面的搜索策略,最后在2010年8月进行,以确定所有的系统评价湿疹预防。我们确定了所有评论,符合我们预先指定的入选标准和数据提取,分析,汇编成表,并使用定量和定性的方法合成。主要结果:7 39 11 897人参加的有关试验,系统评价,包括在本概述。总体而言,有没有明确的证据表明,任何的主要干预措施审查减少湿疹的发病率。在婴幼儿过敏性疾病的高风险的亚组分析,观察研究发现,与引进的固体在三到六个月纯母乳喂养至少6个月相比,湿疹的发病率降低了60%(危险比(RR):0.40 ; 95%可信区间(CI):0.21,0.78),和一项随机对照试验发现,与没有益生元益生元相比,发病率下降了58%(RR:0.42,95%CI:0.21,0.84)。然而,这些研究结果是基于一个单一的小试,超越了前两年的生活和不干预湿疹的发病率降低的结果。虽然我们预先指定的特应性湿疹的发病率(即湿疹与免疫球蛋白E(IgE)的致敏)的主要结果,诊断为湿疹是否是真正的过敏性数据主要是缺乏系统评价。同样,对过敏性疾病的数据,采用对过敏原皮肤点刺试验或特异性IgE检测,并没有报道中的许多评论。没有干预措施时,报告发现,以减少过敏性疾病。不良事件数据的普遍缺乏,但没有益生菌益生菌对从试验数据显着更多的随地吐痰中的第一个(RR:1.88,95%CI:1.03,3.45)和(RR:1.69,95%CI: 1.02,2.80)个月的生命,但在第一年没有整体增加胃肠道症状的风险。结论:虽然目前还没有明确的证据显示,任何的干预研究概述预防湿疹过敏性疾病的风险没有选择的参与者,有一些证据表明,纯母乳喂养至少6个月,益生元可以减少湿疹的发病率高风险的参与者。然而,这些结论是根据有限的证据方法的缺点。湿疹的预防未来的研究是必要的,应研究不同类型的水解配方,益生元和益生菌,以及增强皮肤的屏障和其他婴幼儿过敏性疾病发展的不同风险水平的新方法。

Broad synthesis / Overview of systematic reviews

Unclassified

期刊 Clinical and experimental dermatology
Year 2011
Loading references information
这次审查提供了来自18个系统评价,过敏性湿疹,2009年1月和2010年8月24日之间公布或索引的主要结果摘要。对有机食品的消费和湿疹的可能的好处也没有很好的证据。产妇摄入鱼或鱼油可能与降低风险的后代湿疹,虽然还需要进一步研究。有一些证据,可能与相关的婴幼儿湿疹的风险降低部分水解婴儿配方奶粉,而不是标准公式,但缺点是在现有的证据。脑胶质瘤之间找到一个反比关系已/急性淋巴细胞白血病和过敏性疾病/湿疹,但似乎有多发性硬化症和湿疹之间没有关联。多动症确实出现了湿疹,但有没有因果联系的证据。似乎在城市与农村地区相比,增加了湿疹的风险。一些新的证据提出了强有力的和温和的皮质类固醇的1%吡美莫司的优势,在6个月而不是12个月,并有一些证据表明超过1%吡美莫司0.03%和0.1%他克莫司的优势。一个更新的Cochrane评价仍然没有发现任何形式antistaphylococcal治疗湿疹临床感染或未受管理的一个好处的证据。沐浴润肤,闭塞的治疗(如潮湿和干燥套),梭织丝绸服装和治疗湿疹的证据基础差。在一般情况下,湿疹最系统评价所采用的方法需要更清楚,特别是考虑到更有力的质量评估,包括研究,报告。纳入研究的是经常异构,代理申报,是常见的,往往缺乏相应的疾病定义。更好地遵守现有的指导试验报告和前瞻性的临床试验登记,可能有助于提高研究质量。

Broad synthesis / Overview of systematic reviews

Unclassified

期刊 Clinical and experimental dermatology
Year 2010
Loading references information
本文综述了临床上重要的原因,治疗和预防过敏性湿疹,2008年八月至2009年8月出版(AE)的九个系统评价结果。两个系统评价得出的结论是有强烈和一致的协会之间的聚角蛋白微丝(FLG)基因突变和湿疹的发展。FLG的基因突变和过敏性过敏,鼻炎和哮喘之间的关联比FLG的基因突变和湿疹较弱,特别是如果排除那些也有湿疹。转化生长因子水平在母乳和湿疹发展之间的关系仍不清楚。进一步系统化审查发现对湿疹至少3个月的纯母乳喂养的保护作用没有有力的证据,即使是在那些有过敏的家族史阳性。基于系统回顾和荟萃分析的6个随机对照试验,补充ω-3和ω-6的油是不可能在一般的湿疹或过敏性疾病的初级预防中发挥重要作用。很少有证据支持某些食物的饮食限制,在未选中的孩子与AE。也很少有证据表明,从成立湿疹患者在使用益生菌临床上有用的好处。外用吡美莫司和他克莫司的一个系统性回顾添加附加信息很少,以前的评论中,并没有提供任何新的长期安全数据。这两种药物在AE工作,并可能降低耀斑和外用皮质类固醇的使用,但是,还有他们如何与外用皮质类固醇的不确定性。